Safety and Immunogenicity of Prime-boost Vaccination of SARS-CoV-2 in Patients With Cancer
Clinical trial NCT05273541 · UNKNOWN
Trial details
- NCT number
- NCT05273541
- Sponsor
- Beijing 302 Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2022-12-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.